First real life data on durvalumab after definitive concomitant chemoradiotherapy (cCRT) in unresectable stage (St) III non-small cell lung cancer (NSCLC) in France: Analysis of 591 patients (pts) enrolled in the French cohort (c) temporary authorization of use (ATU)

V. Avrillon, S. Bota Ouchlif,P. Merle, E. Pichon, A.T. Stancu, C. Chouaid, C. Sire, H. Boudabous, A. Lagrange, M. Sabatini, G. Eberst, P. Boisselier, A. Gourion, A. Lion, A. Lahouegue, K. Belkhiria, I. de La Porte, M. Urbieta, F. Mornex,N. Girard

Annals of Oncology（2019）

引用 0|浏览20

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要